The BLM group had significantly decreased miR-30a level and significantly increased TET1 level compared with the sham group; furthermore, miR-30a agomir could improve the miR-30a expression and inhibit the TET1 expression in the agomir group compared with the BLM group (Figure 4F–H). This evidence concerns the gene TET1 and Bloom syndrome.